Spikevax
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Spikevax in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Spikevax.
17
Global Revenue Ranking
Recent articles on PMLiVE featuring Spikevax
Global health authorities have recommended that vaccines for the 2025-2026 season should target LP.8.1
The combined vaccine approach could simplify immunisation practices and lead to higher uptake
The approach could simplify immunisation practices and lead to higher vaccine uptake
The vaccine has been updated to target the currently circulating XBB.1.5 Omicron variant
The vaccine is already authorised as the third of a three-dose primary series in this age group
New research reveals the industry’s customer experience leaders and laggards in the evolving post-COVID-19 hybrid environment
In the US, RSV causes around 60,000 to 120,000 hospitalisations and 6,000 to 10,000 deaths in older adults each year
The company is also evaluating the use of the vaccine in children aged from six months
Data indicates that the superior response is sustained for at least three months
By Dominic Tyer
The programme was expanded in response to the Omicron variant to include everyone aged 50 and over
The booster dose can be used in adults aged 18 years and over to protect against contracting COVID-19
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology